Global Peptide Screening Service Market Research Report 2026(Status and Outlook)

February 2026 | 112 pages | ID: GFEF908590F0EN
Bosson Research

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Peptide screening service refers to the use of high-throughput technology (such as phage display peptide library, mRNA display, chemical synthesis peptide library screening, etc.) or computational biology methods (such as molecular docking, virtual screening, machine learning model prediction) to systematically screen candidate peptide molecules with specific biological functions (such as high affinity binding to target proteins, regulation of cell signaling pathways, antibacterial and antiviral activity, etc.) or physicochemical properties (such as stability, membrane permeability) from a large-scale peptide sequence collection, and combine experimental verification (such as ELISA, SPR, cell activity detection, etc.) to evaluate their activity and specificity, and ultimately provide customized solutions for lead peptide sequences or functional peptide libraries for application fields such as drug development (such as peptide drugs, vaccine adjuvants), biomaterial design (such as targeted delivery carriers), and diagnostic reagent development. By integrating multi-dimensional screening strategies and activity verification systems, this service significantly shortens the research and development cycle from random peptide libraries to functional peptide molecules, and increases the possibility of discovering highly effective and low-toxic peptide drugs.Peptide screening service refers to the use of high-throughput technology (such as phage display peptide library, mRNA display, chemical synthesis peptide library screening, etc.) or computational biology methods (such as molecular docking, virtual screening, machine learning model prediction) to systematically screen candidate peptide molecules with specific biological functions (such as high affinity binding to target proteins, regulation of cell signaling pathways, antibacterial and antiviral activity, etc.) or physicochemical properties (such as stability, membrane permeability) from a large-scale peptide sequence collection, and combine experimental verification (such as ELISA, SPR, cell activity detection, etc.) to evaluate their activity and specificity, and ultimately provide customized solutions for lead peptide sequences or functional peptide libraries for application fields such as drug development (such as peptide drugs, vaccine adjuvants), biomaterial design (such as targeted delivery carriers), and diagnostic reagent development. By integrating multi-dimensional screening strategies and activity verification systems, this service significantly shortens the research and development cycle from random peptide libraries to functional peptide molecules, and increases the possibility of discovering highly effective and low-toxic peptide drugs.

The global Peptide Screening Service market size was estimated at USD 1274.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.70% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Peptide Screening Service market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Peptide Screening Service market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Peptide Screening Service market.

Global Peptide Screening Service Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

JPT Peptide Technologies
Biosynth
Orbit Discovery
Creative Biolabs
GenScript
Creative Peptides
Eurogentec
Bio-Synthesis
Antibody Design Labs
HLA Proteins
Synbio Technologies
Lugen SCI
Quimigen
IRBM
Eurogentec
New England Peptide

Market Segmentation (by Type)

Solid Phase Screening
Solution Phase Screening
Cell-based Screening

Market Segmentation (by Application)

Peptide Drug Development
Vaccine Development
Others

Geographic Segmentation

North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Peptide Screening Service Market
Overview of the regional outlook of the Peptide Screening Service Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peptide Screening Service Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Peptide Screening Service, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Peptide Screening Service
1.2 Key Market Segments
  1.2.1 Peptide Screening Service Segment by Type
  1.2.2 Peptide Screening Service Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PEPTIDE SCREENING SERVICE MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PEPTIDE SCREENING SERVICE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Peptide Screening Service Product Life Cycle
3.3 Global Peptide Screening Service Revenue Market Share by Company (2020-2025)
3.4 Peptide Screening Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Peptide Screening Service Market Competitive Situation and Trends
  3.6.1 Peptide Screening Service Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Peptide Screening Service Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 PEPTIDE SCREENING SERVICE VALUE CHAIN ANALYSIS

4.1 Peptide Screening Service Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PEPTIDE SCREENING SERVICE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Peptide Screening Service Market Porter's Five Forces Analysis

6 PEPTIDE SCREENING SERVICE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptide Screening Service Market by Type (2020-2025)
6.3 Global Peptide Screening Service Market Size Growth Rate by Type (2021-2025)

7 PEPTIDE SCREENING SERVICE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptide Screening Service Market Size (M USD) by Application (2020-2025)
7.3 Global Peptide Screening Service Market Size Growth Rate by Application (2021-2025)

8 PEPTIDE SCREENING SERVICE MARKET SEGMENTATION BY REGION

8.1 Global Peptide Screening Service Market Size by Region
  8.1.1 Global Peptide Screening Service Market Size by Region
  8.1.2 Global Peptide Screening Service Market Size Market Share by Region
8.2 North America
  8.2.1 North America Peptide Screening Service Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Peptide Screening Service Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Spain
8.4 Asia Pacific
  8.4.1 Asia Pacific Peptide Screening Service Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Peptide Screening Service Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Peptide Screening Service Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 JPT Peptide Technologies
  9.1.1 JPT Peptide Technologies Basic Information
  9.1.2 JPT Peptide Technologies Peptide Screening Service Product Overview
  9.1.3 JPT Peptide Technologies Peptide Screening Service Product Market Performance
  9.1.4 JPT Peptide Technologies SWOT Analysis
  9.1.5 JPT Peptide Technologies Business Overview
  9.1.6 JPT Peptide Technologies Recent Developments
9.2 Biosynth
  9.2.1 Biosynth Basic Information
  9.2.2 Biosynth Peptide Screening Service Product Overview
  9.2.3 Biosynth Peptide Screening Service Product Market Performance
  9.2.4 Biosynth SWOT Analysis
  9.2.5 Biosynth Business Overview
  9.2.6 Biosynth Recent Developments
9.3 Orbit Discovery
  9.3.1 Orbit Discovery Basic Information
  9.3.2 Orbit Discovery Peptide Screening Service Product Overview
  9.3.3 Orbit Discovery Peptide Screening Service Product Market Performance
  9.3.4 Orbit Discovery SWOT Analysis
  9.3.5 Orbit Discovery Business Overview
  9.3.6 Orbit Discovery Recent Developments
9.4 Creative Biolabs
  9.4.1 Creative Biolabs Basic Information
  9.4.2 Creative Biolabs Peptide Screening Service Product Overview
  9.4.3 Creative Biolabs Peptide Screening Service Product Market Performance
  9.4.4 Creative Biolabs Business Overview
  9.4.5 Creative Biolabs Recent Developments
9.5 GenScript
  9.5.1 GenScript Basic Information
  9.5.2 GenScript Peptide Screening Service Product Overview
  9.5.3 GenScript Peptide Screening Service Product Market Performance
  9.5.4 GenScript Business Overview
  9.5.5 GenScript Recent Developments
9.6 Creative Peptides
  9.6.1 Creative Peptides Basic Information
  9.6.2 Creative Peptides Peptide Screening Service Product Overview
  9.6.3 Creative Peptides Peptide Screening Service Product Market Performance
  9.6.4 Creative Peptides Business Overview
  9.6.5 Creative Peptides Recent Developments
9.7 Eurogentec
  9.7.1 Eurogentec Basic Information
  9.7.2 Eurogentec Peptide Screening Service Product Overview
  9.7.3 Eurogentec Peptide Screening Service Product Market Performance
  9.7.4 Eurogentec Business Overview
  9.7.5 Eurogentec Recent Developments
9.8 Bio-Synthesis
  9.8.1 Bio-Synthesis Basic Information
  9.8.2 Bio-Synthesis Peptide Screening Service Product Overview
  9.8.3 Bio-Synthesis Peptide Screening Service Product Market Performance
  9.8.4 Bio-Synthesis Business Overview
  9.8.5 Bio-Synthesis Recent Developments
9.9 Antibody Design Labs
  9.9.1 Antibody Design Labs Basic Information
  9.9.2 Antibody Design Labs Peptide Screening Service Product Overview
  9.9.3 Antibody Design Labs Peptide Screening Service Product Market Performance
  9.9.4 Antibody Design Labs Business Overview
  9.9.5 Antibody Design Labs Recent Developments
9.10 HLA Proteins
  9.10.1 HLA Proteins Basic Information
  9.10.2 HLA Proteins Peptide Screening Service Product Overview
  9.10.3 HLA Proteins Peptide Screening Service Product Market Performance
  9.10.4 HLA Proteins Business Overview
  9.10.5 HLA Proteins Recent Developments
9.11 Synbio Technologies
  9.11.1 Synbio Technologies Basic Information
  9.11.2 Synbio Technologies Peptide Screening Service Product Overview
  9.11.3 Synbio Technologies Peptide Screening Service Product Market Performance
  9.11.4 Synbio Technologies Business Overview
  9.11.5 Synbio Technologies Recent Developments
9.12 Lugen SCI
  9.12.1 Lugen SCI Basic Information
  9.12.2 Lugen SCI Peptide Screening Service Product Overview
  9.12.3 Lugen SCI Peptide Screening Service Product Market Performance
  9.12.4 Lugen SCI Business Overview
  9.12.5 Lugen SCI Recent Developments
9.13 Quimigen
  9.13.1 Quimigen Basic Information
  9.13.2 Quimigen Peptide Screening Service Product Overview
  9.13.3 Quimigen Peptide Screening Service Product Market Performance
  9.13.4 Quimigen Business Overview
  9.13.5 Quimigen Recent Developments
9.14 IRBM
  9.14.1 IRBM Basic Information
  9.14.2 IRBM Peptide Screening Service Product Overview
  9.14.3 IRBM Peptide Screening Service Product Market Performance
  9.14.4 IRBM Business Overview
  9.14.5 IRBM Recent Developments
9.15 Eurogentec
  9.15.1 Eurogentec Basic Information
  9.15.2 Eurogentec Peptide Screening Service Product Overview
  9.15.3 Eurogentec Peptide Screening Service Product Market Performance
  9.15.4 Eurogentec Business Overview
  9.15.5 Eurogentec Recent Developments
9.16 New England Peptide
  9.16.1 New England Peptide Basic Information
  9.16.2 New England Peptide Peptide Screening Service Product Overview
  9.16.3 New England Peptide Peptide Screening Service Product Market Performance
  9.16.4 New England Peptide Business Overview
  9.16.5 New England Peptide Recent Developments

10 PEPTIDE SCREENING SERVICE MARKET FORECAST BY REGION

10.1 Global Peptide Screening Service Market Size Forecast
10.2 Global Peptide Screening Service Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Peptide Screening Service Market Size Forecast by Country
  10.2.3 Asia Pacific Peptide Screening Service Market Size Forecast by Region
  10.2.4 South America Peptide Screening Service Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Sales of Peptide Screening Service by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

11.1 Global Peptide Screening Service Market Forecast by Type (2026-2035)
  11.1.1 Global Peptide Screening Service Market Size Forecast by Type (2026-2035)
11.2 Global Peptide Screening Service Market Forecast by Application (2026-2035)
  11.2.1 Global Peptide Screening Service Market Size (M USD) Forecast by Application (2026-2035)

12 CONCLUSION AND KEY FINDINGS


LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Peptide Screening Service Market Size by Type (M USD)
Table 4. Global Peptide Screening Service Market Size by Application
Table 5. Peptide Screening Service Market Size Comparison by Region (M USD)
Table 6. Global Peptide Screening Service Revenue (M USD) by Company (2020-2025)
Table 7. Global Peptide Screening Service Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Screening Service as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Peptide Screening Service Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Peptide Screening Service Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Peptide Screening Service Market Size by Type (M USD)
Table 22. Global Peptide Screening Service Market Size (M USD) by Type (2020-2025)
Table 23. Global Peptide Screening Service Market Share by Type (2020-2025)
Table 24. Global Peptide Screening Service Market Size Growth Rate by Type (2021-2025)
Table 25. Global Peptide Screening Service Market Size by Application
Table 26. Global Peptide Screening Service Market Size by Application (2020-2025) & (M USD)
Table 27. Global Peptide Screening Service Market Share by Application (2020-2025)
Table 28. Global Peptide Screening Service Market Size Growth Rate by Application (2021-2025)
Table 29. Global Peptide Screening Service Market Size by Region (2020-2025) & (M USD)
Table 30. Global Peptide Screening Service Market Size Market Share by Region (2020-2025)
Table 31. North America Peptide Screening Service Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Peptide Screening Service Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Peptide Screening Service Market Size by Region (2020-2025) & (M USD)
Table 34. South America Peptide Screening Service Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Peptide Screening Service Market Size by Region (2020-2025) & (M USD)
Table 36. JPT Peptide Technologies Basic Information
Table 37. JPT Peptide Technologies Peptide Screening Service Product Overview
Table 38. JPT Peptide Technologies Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 39. JPT Peptide Technologies SWOT Analysis
Table 40. JPT Peptide Technologies Business Overview
Table 41. JPT Peptide Technologies Recent Developments
Table 42. Biosynth Basic Information
Table 43. Biosynth Peptide Screening Service Product Overview
Table 44. Biosynth Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Biosynth SWOT Analysis
Table 46. Biosynth Business Overview
Table 47. Biosynth Recent Developments
Table 48. Orbit Discovery Basic Information
Table 49. Orbit Discovery Peptide Screening Service Product Overview
Table 50. Orbit Discovery Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Orbit Discovery SWOT Analysis
Table 52. Orbit Discovery Business Overview
Table 53. Orbit Discovery Recent Developments
Table 54. Creative Biolabs Basic Information
Table 55. Creative Biolabs Peptide Screening Service Product Overview
Table 56. Creative Biolabs Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Creative Biolabs Business Overview
Table 58. Creative Biolabs Recent Developments
Table 59. GenScript Basic Information
Table 60. GenScript Peptide Screening Service Product Overview
Table 61. GenScript Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 62. GenScript Business Overview
Table 63. GenScript Recent Developments
Table 64. Creative Peptides Basic Information
Table 65. Creative Peptides Peptide Screening Service Product Overview
Table 66. Creative Peptides Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Creative Peptides Business Overview
Table 68. Creative Peptides Recent Developments
Table 69. Eurogentec Basic Information
Table 70. Eurogentec Peptide Screening Service Product Overview
Table 71. Eurogentec Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Eurogentec Business Overview
Table 73. Eurogentec Recent Developments
Table 74. Bio-Synthesis Basic Information
Table 75. Bio-Synthesis Peptide Screening Service Product Overview
Table 76. Bio-Synthesis Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Bio-Synthesis Business Overview
Table 78. Bio-Synthesis Recent Developments
Table 79. Antibody Design Labs Basic Information
Table 80. Antibody Design Labs Peptide Screening Service Product Overview
Table 81. Antibody Design Labs Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Antibody Design Labs Business Overview
Table 83. Antibody Design Labs Recent Developments
Table 84. HLA Proteins Basic Information
Table 85. HLA Proteins Peptide Screening Service Product Overview
Table 86. HLA Proteins Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 87. HLA Proteins Business Overview
Table 88. HLA Proteins Recent Developments
Table 89. Synbio Technologies Basic Information
Table 90. Synbio Technologies Peptide Screening Service Product Overview
Table 91. Synbio Technologies Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Synbio Technologies Business Overview
Table 93. Synbio Technologies Recent Developments
Table 94. Lugen SCI Basic Information
Table 95. Lugen SCI Peptide Screening Service Product Overview
Table 96. Lugen SCI Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Lugen SCI Business Overview
Table 98. Lugen SCI Recent Developments
Table 99. Quimigen Basic Information
Table 100. Quimigen Peptide Screening Service Product Overview
Table 101. Quimigen Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Quimigen Business Overview
Table 103. Quimigen Recent Developments
Table 104. IRBM Basic Information
Table 105. IRBM Peptide Screening Service Product Overview
Table 106. IRBM Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 107. IRBM Business Overview
Table 108. IRBM Recent Developments
Table 109. Eurogentec Basic Information
Table 110. Eurogentec Peptide Screening Service Product Overview
Table 111. Eurogentec Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Eurogentec Business Overview
Table 113. Eurogentec Recent Developments
Table 114. New England Peptide Basic Information
Table 115. New England Peptide Peptide Screening Service Product Overview
Table 116. New England Peptide Peptide Screening Service Revenue (M USD) and Gross Margin (2020-2025)
Table 117. New England Peptide Business Overview
Table 118. New England Peptide Recent Developments
Table 119. Global Peptide Screening Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 120. North America Peptide Screening Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Europe Peptide Screening Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Asia Pacific Peptide Screening Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Peptide Screening Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Middle East and Africa Peptide Screening Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Global Peptide Screening Service Market Size Forecast by Type (2026-2035) & (M USD)
Table 126. Global Peptide Screening Service Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Industry Chain of Peptide Screening Service
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peptide Screening Service Market Size (M USD), 2025-2035
Figure 5. Global Peptide Screening Service Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Peptide Screening Service Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Peptide Screening Service Product Life Cycle
Figure 12. Global Peptide Screening Service Revenue Share by Company in 2025
Figure 13. Peptide Screening Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Peptide Screening Service Revenue in 2025
Figure 15. Value Chain Map of Peptide Screening Service
Figure 16. Global Peptide Screening Service Market PEST Analysis
Figure 17. Global Peptide Screening Service Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Peptide Screening Service Market Share by Type
Figure 20. Market Share of Peptide Screening Service by Type (2020-2025)
Figure 21. Global Peptide Screening Service Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Peptide Screening Service Market Share by Application
Figure 24. Global Peptide Screening Service Market Share by Application (2020-2025)
Figure 25. Global Peptide Screening Service Market Share by Application in 2024
Figure 26. Global Peptide Screening Service Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Peptide Screening Service Market Size Market Share by Region (2020-2025)
Figure 28. North America Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Peptide Screening Service Market Size Market Share by Country in 2024
Figure 30. U.S. Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Peptide Screening Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Peptide Screening Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Peptide Screening Service Market Share by Country in 2024
Figure 35. Germany Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Peptide Screening Service Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Peptide Screening Service Market Size Market Share by Region in 2024
Figure 42. China Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Peptide Screening Service Market Size and Growth Rate (M USD)
Figure 48. South America Peptide Screening Service Market Size Market Share by Country in 2024
Figure 49. Brazil Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Peptide Screening Service Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Peptide Screening Service Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Peptide Screening Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Peptide Screening Service Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Peptide Screening Service Market Share Forecast by Type (2026-2035)
Figure 61. Global Peptide Screening Service Market Share Forecast by Application (2026-2035)


More Publications